首页 | 官方网站   微博 | 高级检索  
     

PAX1基因甲基化特异性定量PCR检测在宫颈癌筛查中的意义
引用本文:徐周敏,秦士新,裴峰,瞿琴.PAX1基因甲基化特异性定量PCR检测在宫颈癌筛查中的意义[J].临床肿瘤学杂志,2013,18(1):10-14.
作者姓名:徐周敏  秦士新  裴峰  瞿琴
作者单位:201103 上海 武警上海市总队医院肿瘤科
摘    要:目的 探讨定量测定配对盒家族基因1(PAX1)甲基化水平在宫颈癌筛查中的意义。方法 收集正常宫颈组织20例、宫颈上皮内瘤变Ⅰ(CINⅠ)组织15例、CINⅡ组织16例、CINⅢ组织19例和宫颈癌组织22例。采用甲基化特异性实时定量聚合酶链反应(QMSP)定量检测不同宫颈组织中PAX1甲基化水平,甲基化特异性PCR(MS-PCR)检测宫颈癌组织PAX1基因区域甲基化情况,并同时行第2代杂交捕获 人乳头瘤病毒 DNA(HC2-HPV-DNA)检测。采用受试者工作特征曲线(ROC)比较两者对宫颈癌的诊断效率。甲基化率通过甲基化指数(PMR)进行指标量化。结果 宫颈癌组织的PMR为(75.27±30.61)%,显著高于CIN Ⅲ的(12.90±10.80)%和其他良性病变及正常组织(P<0.001)。QMSP 检测PAX1甲基化的ROC曲线下面积(AUC)、灵敏度和特异度分别为0.98、100.0%和84.3%,优于HC2-HPV-DNA检测的0.82、100.0%和52.5%,差异有统计学意义(P<0.001)。MS-PCR检测结果显示,在癌组织原发灶、转移性癌组织、毗邻原发灶的正常组织和距原发灶边缘>3cm的正常组织中,PAX1的甲基化率分别为95.0%(19/20)、100.0%(4/4)、70.0%(14/20)和35.0%(7/20),组间比较差异有统计学意义(P<0.001)。结论 QMSP方法定量检测PAX1的甲基化具有极高的灵敏度,且其特异度超过目前常用的HC2-HPV-DNA检测方法,在临床筛查和宫颈癌的早期诊断中可能具有潜在的应用价值。

关 键 词:配对盒家族基因1  DNA甲基化  HPV检测  宫颈癌
收稿时间:2012-09-26
修稿时间:2012-11-19

Quantitative methylation-specific PCR for PAX1 gene and its significance in detection of cervical cancer
XU Zhoumin , QIN Shixin , PEI Feng , QU Qin.Quantitative methylation-specific PCR for PAX1 gene and its significance in detection of cervical cancer[J].Chinese Clinical Oncology,2013,18(1):10-14.
Authors:XU Zhoumin  QIN Shixin  PEI Feng  QU Qin
Affiliation:Department of Oncology, Shanghai Corps Hospital, Chinese People’s Armed Police Forces, Shanghai 201103, China
Abstract:Objective To explore the role of a quantitative measure of the paired boxed gene 1 (PAX1) methylation in detection of cervical cancer. Methods The percentage of PAX1 methylation was detected by real-time quantitative methylation-specific polymerase chain reaction (QMSP) in normal cervical tissues ( n = 20) , cervical intraepithelial neoplasia Ⅰ ( CIN Ⅰ ) tissues ( n = 15 ) , CIN Ⅱ tissues (n = 16), CIN Ⅲ tissues (n = 19) and cervical cancer tissues (n = 22). The methylation status of PAX1 gene in cervical cancer tissues was tested by methylation-specific polymerase chain reaction (MS-PCR). The efficacy of PAX1 in diagnosis of cervical cancer was compared with that of the hybrid capture 2-human papilloma virus-DNA (HC2-HPV-DNA) test by ROC curve. Results The percentage of methylated reference (PMR) in cervical cancer was (75.27±30. 61 )% , significantly higher than ( 12. 90 ± 10. 80) % in CIN Ⅲ and other milder lesions or normal tissues (P 〈 0. 001 ). The area under the ROC curve ( AUC), sensitivity and specificity of PAX1 methylation tested by QMSP was 0. 98, 100. 0% and 84. 3%, better than 0. 82, 100. 0% and 52. 5% of HC2-HPV-DNA test (P 〈 0. 001 ). The MS-PCR test showed that the methylation rate of PAX1 in cervical cancer, metastatic cancer tissue,adjacent normal tissue and remote normal tissue was 95.0% (19/20), 100. 0% (4/4), 70. 0% (14/20) and 35.0% (7/20) with significance( P 〈 0. 001 ). Conclusion Quantitative measurement of PAX1 hypermethylation in eervical serapings is highly sensitive and more specific than HC2-HPV-DNA test in detection of cervical cancer. Quantitative measurement of PAX1 methylation may have a potential value for diagnosis of cervical cancer in clinic.
Keywords:PAX1  DNA methylation  HPV test  Cervical cancer
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《临床肿瘤学杂志》浏览原始摘要信息
点击此处可从《临床肿瘤学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号